This study investigated the cyanoacylation of the sulfapyridine moiety using cyanoacetyl pyrazole as a key synthetic intermediate for the construction of diverse bioactive scaffolds. The intermediate, 2-cyano-N-(4-(N-pyridin-2-yl) sulfamoyl) phenylacetamide, served as a valuable precursor for the synthesis of acrylamide, thiophene, thiazole, chromene, pyridone, 1,2,4-triazine, and hydrazone derivatives all incorporating the sulfapyridine core. The structural elucidation of the synthesized compounds was achieved using infrared (IR), nuclear magnetic resonance (1H and 13C), and mass spectrometry techniques. The biological activity of the newly synthesized compounds was evaluated against a panel of microorganisms, including Gram-positive bacteria (Staphylococcus aureus, Bacillus subtilis), Gram-negative bacteria (Escherichia coli, Pseudomonas aeruginosa), and the fungus Candida albicans. Notably, the thiol derivative (compound 12), the pyrazole derivative (compound 15), and the 1,2,4-triazine derivatives (compound 21) exhibited significant to good antibacterial and antifungal activity. Interestingly, compounds 12 and 15 displayed a broader spectrum of activity, demonstrating efficacy against all tested microbial strains.
Read full abstract